79374383 - VECTORY

Information

  • Trademark
  • 79374383
  • Serial Number
    79374383
  • Filing Date
    June 16, 2023
    a year ago
  • Transaction Date
    January 04, 2025
    3 months ago
  • Status Date
    October 07, 2024
    6 months ago
  • Location Date
    October 07, 2024
    6 months ago
  • Status Code
    601
  • Current Location
    TMEG LAW OFFICE 109 - EXAMINING ATTORNEY ASSIGNED
    Employee Name
    THOMPSON, HEATHER
  • Attorney Docket Number
    19250-0523
    Attorney Name
    Douglas T. Johnson
    Law Office Assigned Location Code
    L90
  • Owners
Mark Drawing Code
4
Mark Identification
VECTORY
Case File Statements
  • GS0051: Viral systems, gene therapy systems, nucleic acid delivery systems, namely, viral vectors, non-viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells transformed by viral vectors, non-viral vectors, gene therapy vectors or nucleic acid delivery vectors for medical purposes; pharmaceutical products; biological preparations for use in medical and clinical gene therapy, nucleic acid-based therapy and cell therapy; clinical medical reagents for use in nucleic acid-based therapy, gene therapy, cell therapy, gene diagnosis and gene testing; pharmaceutical preparations, vaccines, prophylaxis products and other pharmaceutical products for use in nucleic acid-based therapy, gene therapy and cell therapy
  • GS0441: Gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation for the treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders; consultancy in the field of pharmaceutics
  • GS0421: Research, product development and consultancy in the field of biotechnology, biologics, medical science, chemistry and biochemistry; research and product development in the field of pharmaceutics
Case File Event Statements
  • 7/14/2023 - a year ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 7/17/2023 - a year ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 7/21/2023 - a year ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 3/6/2024 - a year ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/10/2024 - a year ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 3/29/2024 - a year ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 3/29/2024 - a year ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 3/9/2024 - a year ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 4/23/2024 - 11 months ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 9/30/2024 - 6 months ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 9/30/2024 - 6 months ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 9/30/2024 - 6 months ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 12/16/2024 - 3 months ago
    15 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR
  • 12/19/2024 - 3 months ago
    16 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 1/4/2025 - 3 months ago
    17 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX
  • 10/7/2024 - 6 months ago
    13 - ABANDONMENT - EXPRESS MAILED Type: ABN1
  • 10/7/2024 - 6 months ago
    14 - ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT Type: MAB1